4//SEC Filing
Plavsic Mark 4
Accession 0001209191-23-002976
CIK 0001434316other
Filed
Jan 10, 7:00 PM ET
Accepted
Jan 11, 4:07 PM ET
Size
5.5 KB
Accession
0001209191-23-002976
Insider Transaction Report
Form 4
Plavsic Mark
Chief Technical Officer
Transactions
- Sale
Common Stock
2023-01-10$5.24/sh−3,418$17,910→ 123,705 total
Footnotes (2)
- [F1]Required number of shares sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of 8,325 shares of Common Stock underlying restricted stock units granted to the Reporting Person on January 25, 2022. This sale was made pursuant to an irrevocable election by the Reporting Person to satisfy tax withholding obligations through a "sell to cover" transaction and does not represent a discretionary trade by the Reporting Person.
- [F2]Represents the weighted average sale price of the shares sold from $5.12 to $5.37 per share. The Reporting Person will provide, upon request by the Commission staff, the Issuer or a security holder of he Issuer, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.
Documents
Issuer
FATE THERAPEUTICS INC
CIK 0001434316
Entity typeother
Related Parties
1- filerCIK 0001868719
Filing Metadata
- Form type
- 4
- Filed
- Jan 10, 7:00 PM ET
- Accepted
- Jan 11, 4:07 PM ET
- Size
- 5.5 KB